2024 Full Event Guide
3 full days of unmissable content sessions covering key challenges from discovery through to the clinic
3 revitalized workshop sessions to take part in intimate discussions with myeloid-cell experts who have faced the same challenges as you
14 industry specific case studies covering the evolving spectrum of myeloid-directed therapies to induce potent anti-tumor immune responses in solid and haem tumors
Uncover the full range of existing and novel targets being discussed from CD40 to LILRB to STING, RORg and PI3-gamma
